<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=137783"><dc:title>Detection of herpes simplex and varicella-zoster virus from skin lesions</dc:title><dc:creator>Jevšnik Virant,	Monika	(Avtor)
	</dc:creator><dc:creator>Lusa,	Lara	(Avtor)
	</dc:creator><dc:creator>Uršič,	Tina	(Avtor)
	</dc:creator><dc:creator>Glinšek Biškup,	Urška	(Avtor)
	</dc:creator><dc:creator>Petrovec,	Miroslav	(Avtor)
	</dc:creator><dc:subject>herpes simplex virus</dc:subject><dc:subject>varicella-zoster virus</dc:subject><dc:subject>skin lesion</dc:subject><dc:subject>isothermal amplification</dc:subject><dc:subject>herpes simplex virus 1</dc:subject><dc:subject>herpes simplex virus 2</dc:subject><dc:description>We compared 2 molecular tests for detection of herpes simplex viruses 1 and 2 (HSV-1, HSV-2) and varicella-zoster virus (VZV): real-time polymerase chain reaction (RT-PCR) (Argene, BioMerieux, France) performed on an LC480 platform (Roche Applied Science, Mannheim, Germany) and isothermal amplification using a Solana HSV1 + 2/VZV assay (Quidel Corporation Worldwide Headquarters, San Diego, CA) with helicase-dependent amplification performed by a Solana® instrument. With both methods, HSV-1 was detected in 68/291 (23.4%), HSV-2 in 23/291 (7.9%), and VZV in 48/291 (16.5%) skin lesions. Both methods agreed completely only in detection of HSV-2 (kappa = 1). Concordance between Solana HSV1 + 2/VZV and RT-PCR was 98.3% (kappa = 0.95) for HSV-1 and 99.3% (kappa = 0.98) for VZV. Rapid detection of HSV-1, HSV-2, and VZV using the Solana platform is a useful method for routine diagnostics and for urgent swab samples requiring a short turnaround time.</dc:description><dc:date>2020</dc:date><dc:date>2022-06-30 14:19:00</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>137783</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
